Summary
Jeffrey Grover is a Senior Scientist specializing in NGS, bioinformatics, and epigenomics with 11 years of experience building reproducible genomic workflows and converting large-scale sequencing data into actionable insights for therapeutic development. At Entrada Therapeutics he established the company’s bioinformatics capabilities, standardized bulk and single-cell RNA-seq pipelines, and led transcriptomic toxicity profiling that informed candidate selection and IND filings. Comfortable across wet lab and computational domains, he manages sequencing instruments, hybrid cloud infrastructure, and multi-user Linux systems while developing automated Nextflow workflows and SOPs for reproducible analysis. His background spans academic and industry settings—from integrating methylation and small RNA datasets in a PhD lab to deploying cloud-native CWL pipelines for the NCI PDXNet—giving him a rare blend of experimental, computational, and operational expertise. Colleagues rely on him as a subject-matter expert who translates complex NGS methods into practical study designs and robust, production-ready analyses.
11 years of coding experience
8 years of employment as a software developer
The University of Arizona
Bachelor of Science (B.S.), Biochemistry & Molecular Biology, Chemistry, Bachelor of Science (B.S.), Biochemistry & Molecular Biology, Chemistry at Michigan State University